Immunotherapy arms race latest: Merck buys Viralytics for $394m
Big pharma pays 160% premium for Australian biotech
X
Immunotherapy arms race latest: Merck buys Viralytics for $394m
https://pharmaphorum.com/news/merck-co-buy-viralytics-cancer-killing-virus-394m/
